AllGLP1
Price tracker
Price alerts
Compare my options
Compare my options
AllGLP1

Compare GLP-1 plans, prices and payment terms. Every price is re-read on the provider’s own site and listed by price only.

Trust & Transparency

  • Our Methodology
  • Affiliate Disclosure
  • Correction Log

Quick Links

  • Zepbound vs Wegovy
  • GLP-1 Side Effects
  • Henry Meds Review
  • Hims Review
  • Direct Meds Review
  • Ivim Health Review

Compare Prices

  • Daily Price Tracker
  • Cheapest GLP-1 Programs
  • GLP-1 Programs Under $200
  • Compounded Semaglutide by Price
  • Compounded Tirzepatide by Price
  • All Providers
  • Compare My Options

Resources

  • GLP-1 Meal Planner
  • GLP-1 Research
  • Nutrition Guide
  • Shortage Tracker
  • Side Effect Explorer
  • Free Widget
  • For Journalists

Company

  • About AllGLP1
  • Contact
  • Privacy Policy
  • Terms of Service
  • Disclaimer

Price Alerts

Tell us what you pay and when you renew. Up to 8 weeks before (you choose), we email the verified prices for your medication, dose and state. Free.

Set up a price alert

Weekly price email

One-click unsubscribe. We never sell your email address.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult with a healthcare provider before starting any medication. AllGLP1 is not a healthcare provider and does not prescribe medications.

Affiliate Disclosure: AllGLP1 may earn a commission when you visit a provider through our links. It never changes which prices are shown or the order they are listed in.

© 2026 AllGLP1. All rights reserved. IP geolocation by DB-IP

PrivacyTermsSitemap
Home/Side Effects/Wegovy

Wegovy Side Effects

Clinical Data & Patient Experiences

FDA Data

Last Updated: January 16, 2026 | Source: FDA Prescribing Information + Patient Discussion Analysis

Clinical Trial Side Effects (FDA Data)

The following adverse reactions were reported in placebo-controlled clinical trials and are listed in Wegovy's FDA-approved prescribing information.

Adverse ReactionPlacebo2.4mg
Nausea6%44%
Diarrhea16%30%
Vomiting5%24%
Constipation10%24%
Abdominal Pain6%11%
Headache10%14%
Fatigue3%11%

Source: FDA Prescribing Information for Wegovy (semaglutide), Table 1

Key Statistics from FDA Label

74%
experienced any GI adverse reaction (vs 47% placebo)
4.5%
discontinued treatment due to GI side effects
1.6%
experienced cholelithiasis (gallstones)
1-4 bpm
mean heart rate increase from baseline

Other Reported Adverse Reactions

  • •Eructation (belching): 3.0-3.3% vs 0.4% placebo
  • •Flatulence: 1.3-2.9% vs 0% placebo
  • •GERD: 1.7-2.5% vs 0.4% placebo
  • •Hypersensitivity reactions: 3.2% vs 1.7% placebo
  • •Injection site reactions: 3.2% vs 0.4% placebo

Post-Marketing Reports (After Approval)

  • •Alopecia (hair loss)
  • •Acute renal failure
  • •Ileus (intestinal blockage)
  • •Pulmonary aspiration during surgery

What Patients Are Experiencing

Patient-reported experiences and clinical data.

Note: Patient-reported patterns are general guidance — consult your clinician for personal advice.

Nausea: Timing & Triggers

Clinical: 44% at 2.4mg dose

Nausea typically peaks 2-4 days post-injection, especially during dose increases. The 2.5mg→5mg transition is often the most challenging.

Common triggers: High-fat meals, eating past fullness, large portions

Relief strategies: Ondansetron, ginger, small frequent meals, avoiding trigger foods

Read the full nausea management guide

Constipation: The Long-Term Challenge

Clinical: 6-7%

Unlike nausea, constipation often worsens over time. Reduced food intake (800-1200 cal/day) plus slowed GI motility creates ongoing issues.

Management: Daily MiraLAX, magnesium citrate, fiber supplements, prevention over reaction

Sulfur Burps: The Signature Side Effect

Clinical: Listed as "eructation" 3.0-3.3%

FDA data understates this. Sulfur burps — the distinctive rotten-egg-tasting belch — are a common complaint, often accompanied by diarrhoea.

Triggers: Fatty foods, eggs, dairy, overeating

Relief: Pepto-Bismol, Gas-X, avoiding trigger foods, smaller meals

Hair Loss: Telogen Effluvium

Clinical: Not in trials; added post-marketing

A common pattern: hair thinning typically appears 3-6 months after starting, likely related to rapid weight loss and caloric restriction (telogen effluvium) rather than the medication directly.

Common approaches: Ensure adequate protein (60-80g/day), biotin, multivitamin; usually resolves as weight stabilizes

Fatigue

Clinical: Not prominently reported in trials

Fatigue is common in the first weeks, often related to dramatically reduced caloric intake.

Management: Track calories (minimum 1000-1200), protein shakes, electrolytes, adequate sleep

When to Call Your Doctor

  • • Severe abdominal pain (possible pancreatitis)
  • • Vision changes
  • • Neck lump, trouble swallowing, hoarseness
  • • Unable to keep liquids down 24+ hours

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider.

Sources: FDA Prescribing Information, patient-reported experiences